Terry Smith
Fundsmith
Terry Smith Zoetis Inc stake
total: 91
Fundsmith ZTS trades
- Total transactions:
- 23
- New positions:
- 1
- Sold out:
- 1
- Added:
- 16
- Reduced:
- 5
- Held since:
- 2020 Q4
- Held for:
- 22 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Terry Smith doesn't hold any Zoetis Inc (ZTS) shares. To date, the estimated cost basis is nearly $158.28 for "buy" trades and estimated average "sell" price is $119.07. Fundsmith first purchased ZTS in 2020 Q4, initially acquiring 121,003 shares. Since the initial investment in Zoetis Inc (ZTS), Fundsmith has made 22 more transactions.
When did Terry Smith sell Zoetis Inc (ZTS)?
Terry Smith sold off the entire Zoetis Inc (ZTS) position in 2026 Q2.
When did Terry Smith buy Zoetis Inc (ZTS)?
Terry Smith first invested in Zoetis Inc (ZTS) in 2020 Q4 at the reported quarter-end price of $165.50 per share.
What's the cost basis of Fundsmith's ZTS stake?
The estimated cost basis for Zoetis Inc (ZTS) stake is around $158.28 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $158.28
- Weighted AVG sell price:
- $119.07
Terry Smith's historical trades in Zoetis Inc
23 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$118.21
|
|
-100% (-3,877,559)
|
-3.57%
|
|
2026 Q1
|
3.57%
|
3,877,559
|
$118.21
|
$458,366,249
|
-0.60% (-23,244)
|
-0.02%
|
|
2025 Q4
|
2.87%
|
3,900,803
|
$125.82
|
$490,799,033
|
+7.90% (+285,672)
|
+0.21%
|
|
2025 Q3
|
2.67%
|
3,615,131
|
$146.32
|
$528,965,968
|
+25.32% (+730,300)
|
+0.54%
|
|
2025 Q2
|
1.95%
|
2,884,831
|
$155.95
|
$449,889,394
|
+13.29% (+338,344)
|
+0.23%
|
|
2025 Q1
|
1.91%
|
2,546,487
|
$164.65
|
$419,279,085
|
+1,020.18% (+2,319,158)
|
+1.74%
|
|
2024 Q4
|
0.16%
|
227,329
|
$162.93
|
$37,038,714
|
-1.47% (-3,397)
|
-0%
|
|
2024 Q3
|
0.18%
|
230,726
|
$195.38
|
$45,079,246
|
+1.10% (+2,521)
|
+0%
|
|
2024 Q2
|
0.16%
|
228,205
|
$173.36
|
$39,561,619
|
-0.26% (-600)
|
-0%
|
|
2024 Q1
|
0.15%
|
228,805
|
$169.21
|
$38,716,094
|
+1.21% (+2,741)
|
+0%
|
|
2023 Q4
|
0.19%
|
$197.37
|
+1.46% (+3,261)
|
|||
|
2023 Q3
|
0.18%
|
$173.98
|
+0.19% (+417)
|
|||
|
2023 Q2
|
0.16%
|
$172.21
|
-1.30% (-2,923)
|
|||
|
2023 Q1
|
0.16%
|
$166.44
|
+0.60% (+1,353)
|
|||
|
2022 Q4
|
0.15%
|
$146.55
|
+0.35% (+771)
|
|||
|
2022 Q3
|
0.16%
|
$148.29
|
+0.51% (+1,132)
|
|||
|
2022 Q2
|
0.17%
|
$171.89
|
+0.74% (+1,625)
|
|||
|
2022 Q1
|
0.14%
|
$188.59
|
-16.38% (-43,186)
|
|||
|
2021 Q4
|
0.16%
|
$244.03
|
+9.61% (+23,112)
|
|||
|
2021 Q3
|
0.13%
|
$194.14
|
+9.04% (+19,947)
|
|||
|
2021 Q2
|
0.11%
|
$186.36
|
+3.93% (+8,348)
|
|||
|
2021 Q1
|
0.11%
|
$157.48
|
+75.37% (+91,204)
|
|||
|
2020 Q4
|
0.07%
|
$165.50
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.